Marta Kramer Mikkelsen

Marta Kramer Mikkelsen

Auto-generated profile, based on publicly available information

Marta Kramer Mikkelsen

Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte, Borgmester Ib Juuls vej 1, Herlev, 2730, Denmark; Copenhagen Research Center for Cancer Rehabilitation (CORE-Cancer), Copenhagen University Hospital, Herlev and Gentofte, Borgmester Ib Juuls vej 1, Herlev, 2730, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen N, 2200, Denmark

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in European Journal of Oncology Nursing
Verified
Journal Article
Open access
MMMarta Kramer Mikkelsen
Marta Kramer Mikkelsen
DNDorte NIELSEN
Dorte NIELSEN
AVAnders Vinther
Anders Vinther
CLCecilia Margareta Lund
Cecilia Margareta Lund
MJMary Jarden
Mary Jarden
Older patients with cancer are underrepresented in exercise-based trials. To engage older patients in physical activity (PA), it is necessary to consider age-related decline in health, comorbidities and practicalities. The study aim was to explore attitudes towards PA and exercise among older patients with cancer to inform future exercise-based interventions. Individual interviews (N = 23) were conducted in patients ≥ 65 years with advanced lung, biliary tract and pancreatic cancer receiving palliative oncological treatment. Patients were recruited with a purposive sampling strategy. A semi-structured interview guide focusing on attitudes towards PA and exercise, including barriers, facilitators and motivators, was used. Data on the informants' medical history, demographics and PA level was collected. Identified themes were: 1) a general positive perception of physical activity is expressed 2) comorbidities and external circumstances prevent physical activity, 3) fatigue overshadows life, 4) social support is key to short and long-term motivation, 5) fixed conditions keep one focused, 6) familiarity raises confidence and motivation. Even though perceptions of PA were positive among older patients with cancer, most struggled to stay physically active during oncological treatment. Several factors related to cancer and aging were identified as barriers; most profoundly was the overwhelming feeling of fatigue. Improving physical and mental well-being, fixed conditions (e.g. group-based exercise and supervision) and social support were identified as motivators and facilitators. Preferences for PA varied, but activities that were familiar increased motivation. Exercise programs for older patients with cancer must be adjustable to each patient's limitations, needs and personal resources.

19 October 2020 in European Review of Aging and Physical Activity
Verified
Journal Article
Open access
PDF file
MMMarta Kramer Mikkelsen
Marta Kramer Mikkelsen
CJCarsten Bogh Juhl
Carsten Bogh Juhl
CLCecilia Margareta Lund
Cecilia Margareta Lund
MJMary Jarden
Mary Jarden
AVAnders Vinther
Anders Vinther
DNDorte NIELSEN
Dorte NIELSEN
Older patients with cancer are underrepresented in trials investigating the effect of exercise therapy. The aim of this systematic review was to investigate the effect of exercise therapy during medical antineoplastic treatment in older patients (≥ 65 years) with cancer. A systematic review following the Cochrane guidelines was performed. Randomized controlled trials were identified through a systematic literature search in MEDLINE, EMBASE, CENTRAL, and CINAHL up to December 2019. Study selection was performed independently by two reviewers. Four randomized controlled trials published between 2014 and 2019 were included comprising a total of 412 participants. Most participants were diagnosed with breast, prostate or colorectal cancer. The studies were characterized by large differences in design, interventions and outcomes, which prevented meta-analyses. The interventions ranged from 4 weeks to 12 months and involved both supervised and unsupervised exercise programs. Some evidence of beneficial effects from the interventions were documented on physical function, muscle strength, physical activity and cognitive function. No evidence of effects was found for health-related quality of life, aerobic capacity, body composition, cancer-related symptoms and side effects, or for any clinical outcomes. No adverse events were reported. Exercise therapy seems to be safe and feasible in older patients with cancer. However, due to a limited number of studies, small sample sizes and heterogeneity across study design, the effects of exercise in older patients with cancer receiving medical antineoplastic treatment are inconclusive.

1 December 2020 in Clinical Colorectal Cancer
Verified
Journal Article
Open access
CLCecilia M. Lund
Cecilia M. Lund
TDTroels Gammeltoft Dolin
Troels Gammeltoft Dolin
MMMarta K. Mikkelsen
Marta K. Mikkelsen
CJCarsten B Bogh Juhl
Carsten B Bogh Juhl
AVAnders Vinther
Anders Vinther
DNDorte NIELSEN
Dorte NIELSEN
The incidence of colorectal cancer (CRC) increases with older age. Cancer and treatment-related side effects often lead to physical decline, poor treatment adherence, and a lower quality of life. The aim of the present systematic review and meta-analysis was to evaluate the effects of exercise reported by randomized controlled trials (RCTs) on physical function, physical fitness (ie, aerobic capacity, muscle strength) physical activity, and psychological well-being in older patients with CRC undergoing chemotherapy. Eight RCTs with 552 participants were included in the meta-analysis. The mean age across the RCTs was 58.5 years, and 2 RCTs excluded patients aged > 80 years. The meta-analyses showed a low level of evidence for a small beneficial effect of exercise on self-reported physical function (standardized mean difference [SMD], 0.26; 95% confidence interval [CI], 0.04-0.48) and global quality of life (SMD, 0.22; 95% CI, 0.02-0.43) and low level of evidence for a moderate effect of exercise reducing fatigue (SMD, -0.49; 95% CI, -0.79 to -0.19) for patients receiving chemotherapy for CRC. We found no evidence for a beneficial effect of exercise on physical fitness. No adverse events related to the exercise interventions were reported. The evidence for the effect of exercise on physical outcomes and psychological well-being during chemotherapy for patients with CRC and especially for older patients is sparse. However, exercise during chemotherapy for patients with CRC is feasible and safe. We found a moderate to high risk of bias in most of the included studies, small sample sizes, and a low number of included patients. Moreover, all studies had excluded patients with comorbidities or walking impairment, a group of patients who would probably benefit the most from exercise. This positive result requires verification in larger trials of older and frail patients receiving chemotherapy for CRC.

27 September 2018 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MMMarta Kramer Mikkelsen
Marta Kramer Mikkelsen
CLCecilia Margareta Lund
Cecilia Margareta Lund
AVAnders Vinther
Anders Vinther
ATAnders Tolver
Anders Tolver
ARAnne-Mette Ragle
Anne-Mette Ragle
MJMary Jarden
Mary Jarden
Several intervention studies have demonstrated that exercise training has beneficial effects among cancer patients. However, older cancer patients are underrepresented in clinical trials, and only few exercise-based studies have focused specifically on older patients with cancer. In particular, research investigating the effects of exercise training among older patients with advanced cancer is lacking. The purpose of the current study is to investigate the effect of a 12-week multimodal and exercise-based intervention among older patients (≥65 years) with advanced pancreatic, biliary tract or lung cancer, who are treated with first-line palliative chemotherapy, immunotherapy or targeted therapy. PACE-Mobil-PBL is a two-armed randomized controlled trial. Participants will be randomized 1:1 to an intervention group (N = 50) or a control group (N = 50). Participants in the intervention group will receive standard oncological treatment and a 12-week multimodal intervention, comprised of: (I) supervised exercise training, twice weekly in the hospital setting, (II) home-based walking with step counts and goal-setting, (III) supportive and motivational nurse-led counseling, and (IV) protein supplement after each supervised training session. Participants in the control group will receive standard oncological treatment. The primary outcome is physical function measured by the 30-s chair stand test. Secondary outcomes include measures of feasibility, activity level, physical capacity and strength, symptom burden, quality of life, toxicity to treatment, dose reductions, inflammatory biomarkers, body weight and composition, hospitalizations and survival. Assessments will be conducted at baseline, and after 6, 12 and 16 weeks. The current study is one of the first to investigate the effect of an exercise-based intervention specifically targeting older patients with advanced cancer. PACE-Mobil-PBL supports the development of health promoting guidelines for older patients with cancer, and the study results will provide new and valuable knowledge in this understudied field. The study was prospectively registered at ClinicalTrials.gov on January 26, 2018 (ID: NCT03411200 ).

27 July 2017 in Scandinavian Journal of Urology
Verified
Journal Article
Closed access
MMMarta Kramer Mikkelsen
Marta Kramer Mikkelsen
FTFrederik Birkebæk Thomsen
Frederik Birkebæk Thomsen
KBKasper Drimer Berg
Kasper Drimer Berg
MJMary Jarden
Mary Jarden
SLSigne Benzon Larsen
Signe Benzon Larsen
KBKlaus Brasso
Klaus Brasso
In several observational studies, statin use has been associated with reduced risk of progression and mortality in men with prostate cancer (PCa). The study aim was to investigate the association between statin use at time of PCa diagnosis and time to PCa progression in men with advanced or metastatic PCa receiving androgen deprivation therapy (ADT) as primary treatment. The study population consisted of all men receiving ADT as primary therapy at two Danish Urological Departments in 2007-2013. The primary outcome was time to progression defined as castration-resistant PCa (CRPC) or PCa death. Survival analyses were conducted with Kaplan-Meier analyses, cause specific Cox proportional hazards models, and competing risk analyses. A total of 537 men were included, of whom 141 were statin users at time of diagnosis. The median follow-up time was 5.7 years (95% CI: 5.1-6.2). No significant difference in progression-free survival between statin users and non-statin users was observed at 5 years; 29% for statin users (95% CI: 19-40%) and 28% (95% CI: 23-34%) for non-statin users, p = 0.31. In multivariable Cox analyses, there was no significant association between statin use and risk of progression, HR 0.98 (95% CI: 0.72-1.32). In competing risk analyses the 5-year cumulative incidence of progression was 55% (95% CI: 46-64%) for statin users and 62% (95% CI: 57-67%) for non-statin users, p = 0.11. In the current study, statin use at time of PCa diagnosis was unrelated to time to progression in men primarily treated with ADT.

24 March 2026 in European Journal of Oncology Nursing
Verified
Journal Article
Open access
MMMarta Kramer Mikkelsen
Marta Kramer Mikkelsen
CHCharlotte Hald
Charlotte Hald
KPKarin Piil
Karin Piil
LRLouise Rolin
Louise Rolin
JRJosephine Reimer
Josephine Reimer
KPKathrine Hoffmann Pii
Kathrine Hoffmann Pii
Pancreatic cancer entails poor prognosis and high physical and psychosocial burden for patients and their caregivers. Supportive care needs remain insufficiently addressed. This study aimed to identify supportive care needs and potential directions for future research based on perspectives of patients, caregivers, and healthcare professionals. A qualitative design was applied using focus group interviews. Participants were patients with pancreatic cancer receiving chemotherapy ((neo)adjuvant and palliative), caregivers, and HCPs (oncologists, nurses, physiotherapists, and dieticians). Six focus group interviews were conducted, audio-recorded, transcribed, and analyzed. Identified themes were categorized, described and translated into potential research questions. Nine patients, eight caregivers, and eight health care professionals participated. Twenty-one themes were identified, organized, and consolidated into 10 themes representing patient and caregiver needs. These included: 1) Nutritional guidance beyond generic advice, 2) Information and guidance for self-management of side effects, 3) Supporting caregivers' self-care, 4) Clear information on treatment trajectory and prognosis, 5) Peer support and network, 6) Support for exercise, 7) Existential support, 8) Support and facilitation of family communication, 9) Navigating the treatment trajectory, and 10) Supporting energy management. These themes informed the development of exploratory and interventional research questions intended to guide future supportive care research. The findings highlight a broad range of supportive care needs among patients with pancreatic cancer and their caregivers. While exploratory in nature, the study identifies potential areas for future research and underscores the importance of addressing caregiver burden and family communication within supportive care interventions.